Please use this identifier to cite or link to this item:
|Title:||Hepatitis due to nitrofurantoin.||Austin Authors:||Mollison, L C;Angus, Peter W ;Richards, Michael J;Jones, Robert M ;Ireton, J||Affiliation:||Austin Hospital, Heidelberg, VIC.||Issue Date:||2-Mar-1992||Publication information:||Medical Journal of Australia; 156(5): 347-9||Abstract:||To report three cases of hepatitis related to the use of nitrofurantoin.Two patients who had been taking nitrofurantoin for several years, presented with severe liver failure. In both, the drug had been continued despite evidence of liver injury. A third patient presented with acute hepatitis after six weeks of nitrofurantoin therapy.One of the patients with liver failure died and the other underwent a successful liver transplantation. The third patient recovered after withdrawal of the drug.These cases emphasise the potential for serious hepatic reactions with nitrofurantoin, the danger of continuing the drug once liver damage has occurred and the need for careful monitoring of liver function during long-term therapy.||Gov't Doc #:||1588868||URI:||http://ahro.austin.org.au/austinjspui/handle/1/9926||URL:||https://pubmed.ncbi.nlm.nih.gov/1588868||Type:||Journal Article||Subjects:||Adult
Drug-Induced Liver Injury.etiology
Hepatic Encephalopathy.chemically induced
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 2, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.